Skip to content
Clinical Trials – home

Sint Maartenskliniek Stichting

Research siteFast reply

The Netherlands Hengstdal 3, 6574 NA Ubbergen, The Netherlands

  • 6 trials recruiting
  • Rheumatoid arthritis · Osteoarthritis · Polymyalgia rheumatica
  • Adult patients

About Specializations

Sint Maartenskliniek Stichting in Ubbergen, The Netherlands specialises in clinical trials of conditions such as Rheumatoid arthritis, Osteoarthritis, Polymyalgia rheumatica, Axial spondyloarthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Musculoskeletal Diseases

At Sint Maartenskliniek Stichting in Ubbergen, much of the clinical research focuses on musculoskeletal diseases, especially osteoarthritis, hand osteoarthritis, and related joint conditions. These studies are designed to evaluate treatments that may reduce pain, improve function, and delay the need for joint replacement.

  • Research on osteoarthritis and hand osteoarthritis to test symptom relief and longer-term joint outcomes
  • Studies assessing whether existing therapies can improve pain control and preserve mobility
  • Clinical work aimed at better understanding treatment effectiveness in everyday rheumatology care

This area reflects a strong interest in practical treatment strategies for common joint disorders, with a clear focus on improving daily life for people living with chronic musculoskeletal disease.

Immune System Diseases

The site also conducts research in immune system diseases, particularly rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and polymyalgia rheumatica. These trials are centered on finding better ways to control inflammation, reduce steroid use, and optimize long-term treatment.

  • Studies in rheumatoid arthritis exploring treatment adjustment and disease control
  • Research in psoriatic arthritis and axial spondyloarthritis focused on treatment reduction strategies
  • Trials in polymyalgia rheumatica evaluating therapies that may improve remission and reduce dependence on corticosteroids

These investigations support more personalized care for inflammatory conditions, with the aim of maintaining disease control while limiting unnecessary medication exposure.

Bacterial Infections and Mycoses

Another important research area at the hospital/clinic is bacterial infection research, especially prosthetic joint infection. The trials in this field are examining whether newer antibiotic approaches can be as effective as traditional combination treatments after joint replacement infection.

  • Clinical research on prosthetic joint infection to compare treatment approaches for infected implants
  • Studies focused on improving antibiotic selection for better recovery and fewer complications
  • Work aimed at strengthening infection management after orthopedic procedures

This line of research is important for helping patients recover safely after joint surgery and for improving the treatment of difficult-to-manage bacterial infections.

Analytical, Diagnostic and Therapeutic Techniques and Equipment

The clinical trial portfolio also includes research into therapeutic techniques and treatment optimization, with studies assessing how dosing strategies and targeted therapies can improve outcomes in rheumatologic diseases. These projects look at better ways to use established medicines more effectively.

  • Trials evaluating treatment optimization in rheumatoid arthritis through dose adjustment strategies
  • Research on targeted therapy use in polymyalgia rheumatica to improve disease control
  • Studies testing whether treatment reduction can remain effective in stable inflammatory disease

This area highlights a practical approach to improving care by refining how therapies are used in real-world rheumatology practice.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hengstdal 36574 NA UbbergenThe Netherlands
Recruiting now
6 trials
Conditions studied
8

More sites in UbbergenThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Sint Maartenskliniek Stichting

Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Sint Maartenskliniek Stichting

Osteoarthritis

Recruiting

Study of intramuscular methylprednisolone acetate to treat pain in patients with hand osteoarthritis

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Sint Maartenskliniek Stichting

Study on Adjusting Tocilizumab Doses for Patients with Rheumatoid Arthritis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam

Osteoarthritis

Recruiting

Study on Colchicine for Patients with Knee or Hip Osteoarthritis

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Sint Maartenskliniek Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Clindamycin
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Study on Rituximab for Reducing Steroid Use in Newly Diagnosed Polymyalgia Rheumatica Patients

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Sint Maartenskliniek Stichting

Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Sint Maartenskliniek Stichting

Gouty arthritis+1

Not recruiting

Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Allopurinol
  • Sponsor:Sint Maartenskliniek Stichting
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.